Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer.

ABSTRACT:

Background

Magnetic resonance imaging (MRI)-based risk calculators (MRI-RCs) individualise the likelihood of clinically significant prostate cancer (csPCa) and improve candidate selection for prostate biopsy beyond the Prostate Imaging Reporting and Data System (PI-RADS).

Objective

To compare the Barcelona (BCN) and Rotterdam (ROT) MRI-RCs in an entire population and according to the PI-RADS categories.

Design setting and participants

A prospective comparison of BCN- and ROT-RC in 946 men with suspected prostate cancer in whom systematic biopsy was performed, as well as target biopsies of PI-RADS ≥3 lesions.

Outcome measurements and statistical analysis

Saved biopsies and undetected csPCa (grade group ≥2) were determined.

Results and limitations

The csPC

SUBMITTER: Morote J 

PROVIDER: S-EPMC10334241 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature